US-listed companies
Liminal BioSciences Inc.

Liminal BioSciences Inc.LMNL

Market cap

P/E ratio

Income statement Balance sheet Cash flow

	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Profit (loss) from continuing operations	-234	-122	-45	-29
Net income (loss) from discontinued operations during the year	27	3	57	30
Finance costs and foreign exchange	13	8	4	-17
Gain from disposition of capital and intangible assets	-	-0	-0	-2
Non Cash Issuance Of Warrants	-	2	-	-
Loss (gain) on sale of discontinued operations (note 6)	-	-	-	1
Adjustments for fair value losses (gains)	-1	-1	-10	-2
Impairment losses (note 23)	12	21	2	-
Deferred income taxes (note 24)	0	-	0	0
Gain Loss On Extinguishments Of Liabilities	92	-0	-0	0
Adjustments for provisions	-	-	22	-16
Adjustments for share-based payments	22	6	4	2
Depreciation of capital assets	4	3	1	0
Depreciation expense	5	5	1	1
Amortization of intangible assets	1	1	2	0
Cash flows from (used in) operations before changes in working capital	-85	-77	-101	-32
Change in non-cash working capital items	14	-1	-1	0
Cash flows used in operating activities	-99	-76	-100	-32
Proceeds from issuing shares	119	40	-	-
Proceeds from borrowings, classified as financing activities	20	32	-	-
Repayment of principal on long-term debt (note 16)	1	0	-	39
Repayment of interest on long-term debt (note 16)	4	2	4	-
Exercise of options (note 17b)	-	0	-	-
Proceeds From Exercise Of Pre Funded Warrants	-	0	-	-
Payments of principal on lease liabilities (note 13)	8	7	3	5
Payment of interest on lease liabilities (note 13)	2	2	1	2
Debt, share and warrants issuance and repayment costs	7	3	0	0
Cash flows used in financing activities	118	57	-8	-45
Additions to capital assets	3	1	0	0
Additions to intangible assets	2	1	0	0
Proceeds from sale of discontinued operations business (note 6)	44	5	173	-
Proceeds From Disposal Of Capital Assets From Discontinued Operations	-	-	-	3
Transaction costs paid relating to the sale of discontinued operation business	4	1	2	-
Proceeds from disposal of capital assets	-	0	0	-
Release of restricted cash	0	-	0	-
Interest received	1	0	0	1
Cash flows used in investing activities	36	2	171	4
Net change in cash and cash equivalent during the year	55	-16	63	-73
Effect of exchange rate changes on cash and cash equivalents	-1	-0	1	2